Display options
Cite
Luo LL, Xi M, Yang YD, et al. Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma. J Cancer. 2017;8(17):3441-3447doi: 10.7150/jca.21131.
Luo, L. L., Xi, M., Yang, Y. D., Li, Q. Q., Zhao, L., Zhang, P., Liu, S. L., & Liu, M. Z. (2017). Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma. Journal of Cancer, 8(17), 3441-3447. https://doi.org/10.7150/jca.21131
Luo, Li-Ling, et al. "Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma." Journal of Cancer vol. 8,17 (2017): 3441-3447. doi: https://doi.org/10.7150/jca.21131
Luo LL, Xi M, Yang YD, Li QQ, Zhao L, Zhang P, Liu SL, Liu MZ. Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma. J Cancer. 2017 Sep 20;8(17):3441-3447. doi: 10.7150/jca.21131. eCollection 2017. PMID: 29151927; PMCID: PMC5687157.
Copy Download .nbib Format: NLM
Share it on

J Cancer. 2017 Sep 20;8(17):3441-3447. doi: 10.7150/jca.21131. eCollection 2017.

Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma.

Journal of Cancer

Li-Ling Luo, Mian Xi, Ya-Di Yang, Qiao-Qiao Li, Lei Zhao, Peng Zhang, Shi-Liang Liu, Meng-Zhong Liu

Affiliations

  1. State Key Laboratory of Oncology in South China, Guangdong Esophageal Cancer Institute;Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  2. Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, China.
  3. Imaging Diagnosis and Interventional Center, Cancer Center, Sun Yat-sen University, Guangzhou, China.

PMID: 29151927 PMCID: PMC5687157 DOI: 10.7150/jca.21131

[No abstract available.]

Keywords: Esophageal squamous cell carcinoma; definitive chemoradiotherapy; induction chemotherapy; survival; toxicity.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

  1. Cancer Sci. 2015 Apr;106(4):407-12 - PubMed
  2. Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):517-23 - PubMed
  3. Eur J Cancer. 2005 Mar;41(5):664-72 - PubMed
  4. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2431-8 - PubMed
  5. J Clin Oncol. 2005 Apr 1;23(10):2310-7 - PubMed
  6. Ann Oncol. 2013 Nov;24(11):2844-9 - PubMed
  7. Oncotarget. 2016 Jul 12;7(28):44686-44694 - PubMed
  8. J Clin Oncol. 1999 Sep;17(9):2915-21 - PubMed
  9. J Thorac Oncol. 2007 Jun;2(6):553-68 - PubMed
  10. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 - PubMed
  11. JAMA. 1999 May 5;281(17):1623-7 - PubMed
  12. Cancer. 2008 Sep 15;113(6):1302-8 - PubMed
  13. Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):489-96 - PubMed
  14. J Clin Oncol. 2009 Jan 10;27(2):242-9 - PubMed
  15. Br J Cancer. 2006 Sep 18;95(6):705-9 - PubMed
  16. Med Oncol. 2012 Dec;29(5):3017-23 - PubMed
  17. Br J Cancer. 2011 Jan 18;104(2):265-71 - PubMed
  18. Cancer Chemother Pharmacol. 2016 Jul;78(1):91-9 - PubMed
  19. Jpn J Clin Oncol. 2004 Oct;34(10):615-9 - PubMed
  20. J Clin Oncol. 2008 Oct 1;26(28):4551-6 - PubMed

Publication Types